AI Agents for Regulatory Submissions in Pharma and Life Sciences

Shows how an AI agent can plan, call regulatory tools, and verify outputs for pharma submissions, with a concrete worked example.

By Suhas Bhairav · Updated

Direct Answer

AI agents for regulatory submissions in pharma and life sciences are goal driven, plan steps, call document management, eCTD and eCTD validation tools, retrieve data, and generate drafts. They stay focused on compliance, traceability, and auditable records, while humans retain final approvals and risk judgments.

Best for: Regulatory affairs leads, biostatisticians, and quality assurance professionals.

What AI Agents Can Do in Regulatory Submissions in Pharma and Life Sciences

  • Plan regulatory submission strategy

    Determine target submission type, assemble required documents, map timelines, and select tools for drafting, validation, and audit trails.

  • Collect and verify data

    Pull data from clinical, nonclinical, and manufacturing sources; validate integrity against standards; flag gaps for human review; prepare data packages.

  • Draft modules and summaries

    Compose narrative reports, summaries, and risk assessments using templates and data pulls; ensure compliance with eCTD structure and labeling conventions.

  • Run automated checks

    Execute validation and consistency checks across modules, run style and citation checks, flag discrepancies, and prepare correction tasks.

  • Submit to authority gateways

    Package completed modules, attach metadata, provision audit trails, and submit to electronic regulatory portals with traceability.

  • Produce audit-ready records

    Archive all actions, tool outputs, and decisions with timestamps to support inspections and regulatory review.

How the Agent Works

  1. Receive the goal

    The agent takes a regulatory submission objective (eCTD module, timing window) and defines required artifacts, relevant guidelines, and toolchain to use, aligning with project owners.

  2. Plan

    The agent creates a stepwise plan mapping data sources, document types, validation checks, and tool calls to meet submission requirements and maintain compliance traceability.

  3. Call tools

    The agent executes data pulls from LIMS, clinical databases, and QMS; runs drafting templates, validation scripts, and document converters, collecting results for review.

  4. Check the result

    The agent analyzes outputs for completeness, consistency, and conformance to regulatory rules, and surfaces gaps or deviations for human sign-off or automated remediation.

  5. Finish or hand off

    If all checks pass, the agent finalizes the package and logs provenance; otherwise, it hands off to the regulatory lead with actionable corrections.

Worked Example

Preparing an eCTD submission for a new molecular entity

Illustrative scenario with sample data.

Scenario

A mid-size pharma company needs to submit a new molecular entity dossier to a regulatory authority within a 6-week window while coordinating cross-functional teams.

Input

goal: submit new molecular entity dossier; data: clinical, nonclinical, CMC, risk assessments, labeling drafts; target: authority portal; timeline: 42 days; templates: eCTD, region-specific annexes.

What the agent does

  1. Plan regulatory submission strategy: The agent identifies required modules, templates, and validation checks, then selects tools for drafting and validation, setting a 6-week plan.
  2. Call tools: The agent pulls clinical and nonclinical data from the data lake, retrieves CMC documentation, and runs eCTD validation checks, returning structured module drafts and flagged gaps.
  3. Check the result: The agent reviews module completeness, cross-references regulatory guidance, confirms labeling consistency, and lists outstanding items for human review and remediation.
  4. Finish or hand off: The agent packages modules with metadata, uploads to the submission portal, and creates an auditable trail for inspection; if any gaps exist, it transfers control to the regulatory lead with remediation tasks.

Output

submissionPackage: { eCTD: complete, modules: [clinical, nonclinical, CMC, labeling], validation: pass, metadata: auditTrail, portalLink: provided, deadlines: 42 days }, messages: { status: readyForReview, lastRun: timestamp, nextSteps: notifyTeam }

Human decision

A compliance lead reviews the final package, confirms that all regulatory references are correct, approving the package for submission and authorizing the release of the audit trail and remediation plan.

What You Need

  • Access to the data lake with clinical, nonclinical, and CMC data
  • Templates and guidelines for eCTD sections and regional annexes
  • Permissions to fetch data, generate documents, and submit on the authority portal
  • Logging and audit infrastructure that records tool outputs and user actions

Where People Stay in Charge

  • The agent cannot approve regulatory submissions or overrule policy without a human sign-off.
  • The agent cannot modify core regulatory guidance; a qualified reviewer must confirm interpretations.
  • The agent operates under defined control gates and must hand off to humans for final approvals and risk judgments.

FAQ

What is an AI agent for regulatory submissions in pharma and life sciences?

AI agents for regulatory submissions in pharma and life sciences are goal driven software that plan, call tools to gather data, draft modules, run checks, and either finish the package or hand off to a human for approval. They maintain auditable trails and ensure compliance with submission standards.

What tools does it use to prepare an eCTD submission?

The agent uses data lake access, document templates, eCTD validation scripts, content management systems, and submission portals. It coordinates data pulls from clinical and manufacturing systems, drafts sections, validates formats, and packages modules with metadata for audit trails.

What are the limits of an AI agent in regulatory work?

The agent handles planning, data collection, drafting, and validation within defined rules; it cannot approve regulatory decisions or reinterpret guidance. A qualified person must review outputs that impact risk, labeling, or regulatory strategy.

How is accountability maintained?

All actions generate an auditable trail with timestamps, user identifiers, tool outputs, and decision notes. Every critical step requires human sign-off before final submission or remediation actions proceed.